Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 61 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 8846055

    Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  2. US 8846056

    Anti-RSV immunogens and methods of immunization

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  3. US 8846389

    AAV4 vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  4. US 8846051

    Modulation of replicative fitness by deoptimization of synonymous codons

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  5. US 8846057

    Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  6. US 8841305

    Activators of the human pyruvate kinase M2 receptor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  7. US 8841266

    Pharmaceutical composition and method for regulating abnormal cellular proliferation

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  8. US 8835613

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  9. US 8835167

    Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  10. US 8835378

    Multi-domain amphipathic helical peptides and methods of their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  11. US 8828717

    Framework residue substituted humanized COL-1 antibodies and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  12. US 8828380

    Method for the treatment of pulmonary disease and method of producing proteins of use therein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  13. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  14. US 8829022

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  15. US 8828936

    Therapeutic use of SCGB3A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  16. US 8822540

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  17. US 8822434

    Compositions and methods to treat cardiac diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  18. US 8822196

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  19. US 8822192

    Human rotavirus vaccine strains and diagnostics

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  20. US 8821866

    Methods of treating and preventing colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  21. US 8815229

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  22. US 8816059

    Method for predicting and detecting tumor metastasis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  23. US 8809502

    Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  24. US 8809400

    Method to ameliorate oxidative stress and improve working memory via pterostilbene administration

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.